Clinical Trial Update: An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) [Phase 4]

View source ↗

Summary

An open-label, multicenter Phase IV study of Adefovir Dipivoxil in Korean patients with chronic hepatitis B has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2018-03-26